1/15/2020Review of Chinese Drug Registration Applications and Approvals in 2019

1/15/2020MNC New Product Launches in China Down Slightly to 37 During 2019

1/15/2020National Healthcare Security Working Conference Lays Out Major Tasks i...

1/15/2020U.S. and China Inks Phase One Trade Deal

1/14/2020China Adds Over 6,000 TCM Clinics in 2019

1/14/2020Ambrx and Sino Biopharma Announce Collaboration to Develop Two Next-Ge...

1/14/2020HitGen Enters into DEL-Based Drug Discovery Partnership with Kymera

1/14/2020Chi-Med Initiates a PII Trial of Surufatinib in Combo with Toripalimab...

1/13/2020BeiGene In-licences Candidates from EUSA Pharma

1/11/2020Recent Executive Moves

1/11/2020NMPA Clears Phase 3 Trial for SB12, Samsung Bioepis' Biosimilar Eculiz...

1/8/2020CDE Seeks Comments on Guidelines for Generic Drug Research of Paclitax...

1/8/2020HK Researcher Discovers Anticancer NCE Phorbiplatin

1/7/2020Innovent and Sirnaomics Cooperate to Combine Sintilimab and RNAi in th...

1/7/2020Sorrento, Mabpharm File NDA for Infliximab Biosimilar

1/7/2020NMPA Issues Interim Guidelines for Use of Real-World Data to Support D...

1/6/2020GlycoMimetics and Apollomics Agree to Develop and Commercialize Uprole...

1/6/2020Boehringer Ingelheim's Bet on Chinese CDMO Market Pays Off with Beigen...

1/6/2020Eisai Launches First-in-Class Anti-epileptic Fycompa in China

1/3/2020Recent Executive Moves

1/3/2020CDMO WuXi STA Opens Manufacturing Facility to Produce Oligonucleotides

1/3/2020NHC Issues the Clinical Pathways for Relevant Disease Groups (2019)

1/3/2020Amgen Closes Acquisition of 20.5% Stake in BeiGene for $2.8B

1/2/2020U.S.-China Phase I Trade Deal - An Opportunity Window MNCs Must Not Mi...

1/2/2020NHC and SATCM Issues Rules for Internal Price Practices of Medical Ins...

1/2/2020AstraZeneca Granted Chinese Approval for Its Hyperkalaemia Drug ZS-9

12/31/2019Financial-related Company News in Brief

12/31/2019NMPA Announces Initiation of Drug Business Application System

12/30/2019Bankrupt Achaogen Sells China Assets to Xuanzhu for $4.5M

12/30/2019China's 'Seaweed' Alzheimer's Drug Is Now Available to Patients

Page:101/334 Total number of articles:9993: [First][<<] [99] [100] [101] [102] [103] [>>] [End]